PAREXEL Announces Several New Patient-Centric Innovations to Address Drug Development Challenges

Solutions Built on the Perceptive Cloud Platform Leverage Mobile and Wearable TechnologyBOSTON, October 9, 2018 – PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that it has developed several new solutions that take a patient-centric approach to addressing drug development. Built on the Perceptive® Cloud platform and leveraging PAREXEL’s relationship with Microsoft, the solutions incorporate mobile and wearable technology to increase access to data and improve the patient experience in clinical... Source: RealWire